Sept. 12, 2024: What’s next for MDMA after FDA rejection? Interpreting a lost Euripidean find
Podcast |
Colorado Matters
Media Type |
audio
Categories Via RSS |
Daily News
News
Publication Date |
Sep 12, 2024
Episode Duration |
00:50:08
Researchers hoped the FDA would approve the drug commonly known as "ecstasy" to help treat PTSD. But now that the FDA has rejected it in a surprise decision, what's next for the psychedelic? Then, two CU Boulder scholars interpret what they believe to be previously unknown fragments of two lost tragedies by the Greek playwright Euripides. And, using mammograms to increase awareness of dense breast tissue.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review